1-15 of 852
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiersRecognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiersUncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
NeuroFrontiersA Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiersImproving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Ethan Meltzer, MD
- advertisement
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
NeuroFrontiersExploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
NeuroFrontiersImplementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiersImmunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
Shruti Raja, MD, MHS
- advertisement
New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiersNew Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
Navigating Emerging Treatment Options in MG
NeuroFrontiersNavigating Emerging Treatment Options in MG
Qihua Fan, MD
Qihua Fan, MD
